Niamh Mangan Clinical Oncology Society of Australia Annual Scientific Meeting 2022

Abstracts this author is presenting:

• Dostarlimab in advanced/recurrent (A/R) mismatch repair deficient/microsatellite instability–high or proficient/stable (dMMR/MSI-H or MMRp/MSS) endometrial cancer (EC): the GARNET study  — Poster session 1